Rutgers Cancer Institute of New Jersey has renewed its Comprehensive Cancer Center designation.
Bernard Fisher, University of Pittsburgh Distinguished Service Professor of Surgery recently celebrated 100thth birthday.
Agios Pharmaceuticals Inc. announced that effective Feb. 1, 2019, David Schenkein will transition to the role of executive chairman of the board of directors and serve as a member of the board's Science & Technology Committee, after a decade-long tenure as CEO. Jacqualyn (“Jackie”) Fouse, Ph.D., a member of the company's board, has been named as Agios' next CEO.
Ruth McCorkle was named an American Academy of Nursing Living Legend. The Living Legend designation is AAN's highest honor and was awarded to seven nursing professionals for 2018. The Academy will honor its Living Legend designees at its annual policy conference in Washington, DC, on Nov. 1.
Vamsidhar “Vamsi” Velcheti has joined Perlmutter Cancer Center at NYU Langone Health as director of thoracic medical oncology.
Perlmutter Cancer Center at NYU Langone Health has expanded its Blood and Marrow Transplant Program.
Siteman Cancer Center opened its first treatment facility in Illinois on Aug. 1. The Swansea, Ill., facility marks Siteman's sixth location overall.
The American Cancer Society and the Global Center for Medical Innovation selected the first project to be funded under a recently launched partnership to identify, fund, and promote promising medical devices and technologies within the ACS portfolio of current or previously-funded research. The goal of the initiative is to identify and solve critical unmet needs through innovative technology solutions to diagnose and treat cancer and bring them to market.
LUNGevity Foundation announced the recipients of its 2018 Career Development Awards for lung cancer research. These awards fund critical lung cancer research projects and offer the recipients world-class mentorship by LUNGevity's prestigious Scientific Advisory Board.
bluebird bio, Inc. and Gritstone Oncology Inc. announced a collaboration to research, develop and commercialize products for the treatment of cancer using cell therapy.
